|
🐜
|
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
21 auth.
J. Eron,
B. Young,
D. Cooper,
M. Youle,
E. Dejesus,
J. Andrade-Villanueva,
C. Workman,
R. Zajdenverg,
G. Fätkenheuer,
D. Berger,
...
Princy N. Kumar,
A. Rodgers,
M. Shaughnessy,
Monica L Walker,
Richard J. O. Barnard,
Michael D. Miller,
M. Dinubile,
B. Nguyen,
R. Leavitt,
Xia Xu,
P. Sklar
|
8 |
2010 |
8
🐜
|
|
🐜
|
Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK
14 auth.
J. Rockstroh,
E. Dejesus,
J. Lennox,
Y. Yazdanpanah,
M. Saag,
H. Wan,
A. Rodgers,
Monica L Walker,
Michael I. Miller,
M. Dinubile,
...
B. Nguyen,
H. Teppler,
R. Leavitt,
P. Sklar
|
7 |
2013 |
7
🐜
|
|
🐜
|
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.
15 auth.
J. Rockstroh,
J. Lennox,
E. Dejesus,
M. Saag,
A. Lazzarin,
H. Wan,
Monica L Walker,
Xia Xu,
J. Zhao,
H. Teppler,
...
M. Dinubile,
A. Rodgers,
B. Nguyen,
R. Leavitt,
P. Sklar
|
7 |
2011 |
7
🐜
|
|
🐜
|
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
9 auth.
D. Musher,
S. Manoff,
Richard D. McFetridge,
C. Liss,
Rocio D. Marchese,
J. Raab,
...
A. M. Rueda,
Monica L Walker,
Patricia A Hoover
|
6 |
2011 |
6
🐜
|
|
🐜
|
Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK
15 auth.
E. Dejesus,
J. Rockstroh,
J. Lennox,
M. Saag,
A. Lazzarin,
J. Zhao,
H. Wan,
A. Rodgers,
Monica L Walker,
Michael I. Miller,
...
M. Dinubile,
B. Nguyen,
H. Teppler,
R. Leavitt,
P. Sklar
|
5 |
2012 |
5
🐜
|
